Search
Search Results
##search.searchResults.foundPlural##
-
DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES: ANALOGIES AND DIFFERENCES DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES
1427HTML: 486PDF: 846 -
CONCISE REVIEW ON THE FREQUENCY, MAJOR RISK FACTORS AND SURVEILLANCE OF HEPATOCELLULAR CARCINOMA (HCC) IN ?-THALASSEMIAS: PAST, PRESENT AND FUTURE PERSPECTIVES Thalassaemia transfusion dependent, Hepatitis C, hepatocarcinoma.
4323PDF: 1542HTML: 462 -
How I treat acute and persistent sickle cell pain
2012PDF: 1132HTML: 495 -
PARASITIC INFECTIONS IN HEMATOPOIETIC STEM CELL TRANSPLANTATION
3748PDF: 1257HTML: 3911Untitled: 239Untitled: 275 -
-
PREVALENCE OF HEPATITIS B, HEPATITIS C AND HIV IN MULTIPLY TRANSFUSED SICKLE CELL DISEASE PATIENTS FROM OMAN HBV,HCV and HIV and Sickle Cell Disease.
1680PDF: 1023HTML: 375 -
ROLE OF CYTOKINES AS MOLECULAR MARKER OF DENGUE SEVERITY
3231PDF: 1190HTML: 465 -
AGE AT DIAGNOSIS OF SICKLE CELL ANAEMIA IN LAGOS, NIGERIA
2046PDF: 923HTML: 1875 -
APPROACHING THE TARGET: THE PATH TOWARDS AN EFFECTIVE MALARIA VACCINE
2617PDF: 993HTML: 15126 -
TUBERCULOSIS: EPIDEMIOLOGY AND CONTROL
7157PDF: 4028HTML: 24901 -
NOVEL DRUGS IN FOLLICULAR LYMPHOMA
4573PDF: 1539HTML: 1565Untitled: 243 -
ASSESSMENT OF DIAGNOSTIC TECHNIQUES OF URINARY TUBERCULOSIS
2130PDF: 792HTML: 2353Untitled: 222 -
EPIDEMIOLOGY OF THERAPY-RELATED MYELOID NEOPLASMS IN THE NORDIC COUNTRIES
2269PDF: 837HTML: 1640Figure 1: 208Table 1: 225 -
FROM LEGACY TO INNOVATION: PIDOTIMOD’S EXPANDING THERAPEUTIC HORIZON Pidotimod: Revisiting a Classic Immunomodulator
2818PDF: 1001HTML: 647 -
LETERMOVIR PRIMARY CYTOMEGALOVIRUS PROPHYLAXIS IN ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANT RECIPIENTS: COULD INFECTION AND DISEASE NO LONGER BE A SIGNIFICANT PROBLEM? Letermovir and Cytomegalovirus Prophylaxis in HSCT
1358PDF: 1031HTML: 127 -
The Outcome of Six Patients with COVID-19 Infection and Multiple Myeloma. A Case Series and Literature Review COVID-19 in Multiple Myeloma patients
1027PDF: 376HTML: 210 -
STUDY OF SERUM HAPTOGLOBIN LEVEL AND ITS RELATION TO ERYTHROPOIETIC ACTIVITY IN BETA THALASSEMIA CHILDREN .
2247PDF: 1185HTML: 2599Study of serum haptoglobin level in thalassemia: 368Figures: 194 -
Spontaneous rupture of malarial spleen: report of two cases
838PDF: 413HTML: 2879jdoe, cover letter.doc: 184 -
IS THERE A ROLE FOR MINIMAL RESIDUAL DISEASE MONITORING IN FOLLICULAR LYMPHOMA IN THE CHEMO-IMMUNOTHERAPY ERA?
3445PDF: 1312HTML: 2234Fi.1 Gritti.Rambaldi: 217 -
-
EPIDEMIOLOGICAL OVERVIEW OF HODGKIN LYMPHOMA ACROSS THE MEDITERRANEAN BASIN
3603PDF: 1250HTML: 5008Incidence age-standardized rates for HL across the Mediterranean basin: 219 -
DIAGNOSIS OF MALARIA INFECTION WITH OR WITHOUT DISEASE
3673PDF: 1134HTML: 23358 -
Pidotimod in paucisymptomatic SARS-CoV2 infected patients Pidotimod in COVID-19
3158PDF: 1895HTML: 984







